Search

Your search keyword '"de Gruijl, Tanja D."' showing total 3 results
Start Over Author "de Gruijl, Tanja D." Topic cancer vaccines Journal cancer immunology, immunotherapy
3 results on '"de Gruijl, Tanja D."'

1. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Author

Koster, Bas D., Santegoets, Saskia J. A. M., Harting, Jorien, Baars, Arnold, van Ham, S. Marieke, Scheper, Rik J., Hooijberg, Erik, de Gruijl, Tanja D., and van den Eertwegh, Alfons J. M.

Subjects
BCG vaccines, HEPATITIS B vaccines, CANCER vaccines, RENAL cell carcinoma, HEPATITIS associated antigen
Published
2019
Full Text
View/download PDF

2. Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.

Author

De Gruijl, Tanja D., van den Eertwegh, Alfons J. M., Pinedo, Herbert M., and Scheper, Rik J.

Subjects
*VACCINATION, *CELL tumors, *DENDRITIC cells, *COLON cancer, *CANCER vaccines, *CANCER cells, *THERAPEUTICS
Abstract

The field of tumor vaccination is currently undergoing a shift in focus, from individualized tailor-made vaccines to more generally applicable vaccine formulations. Although primarily predicated by financial and logistic considerations, stemming from a growing awareness that clinical development for wide-scale application can only be achieved through backing from major pharmaceutical companies, these new approaches are also supported by a growing knowledge of the intricacies and minutiae of antigen presentation and effector T-cell activation. Here, the development of whole-cell tumor and dendritic cell (DC)-based vaccines from an individualized autologous set-up to a more widely applicable allogeneic approach will be discussed as reflected by translational studies carried out over the past two decades at our laboratories and clinics in the vrije universiteit medical center (VUmc) in Amsterdam, The Netherlands. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

3. Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Author

Koster, Bas D., Santegoets, Saskia J. A. M., Harting, Jorien, Baars, Arnold, van Ham, S. Marieke, Scheper, Rik J., Hooijberg, Erik, de Gruijl, Tanja D., and van den Eertwegh, Alfons J. M.

Subjects
CANCER vaccines, RENAL cell carcinoma
Abstract

In the original publication of the article the following abstract and keywords were inadvertently omitted. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results